Survival Benefits Attributable to the Brazilian National ART Policy
Background: In Brazil, universal provision of antiretroviral therapy (ART) has been guaranteed free of charge to patients since 1996. We sought to quantify the survival benefits attributable to this policy. Methods: We used a mathematical model of HIV disease (CEPAC-International) to estimate life expectancy of HIV-infected patients initiating ART between 1997 and 2013 in Brazil.…